N-Chloromethylphthalimide [for HPLC Labeling] Size:25G facilitating advancements in pharmaceuticals and

facilitating advancements in pharmaceuticals and chemical research

This versatility is essential in advancing nanomedicine

Parkinson's Disease Treatment: It is primarily used as a medication to manage symptoms of Parkinson's disease by inhibiting the enzyme catechol-O-methyltransferase (COMT)

enhancing the efficiency and selectivity of reactions compared to traditional methods

N-Chloromethylphthalimide [for HPLC Labeling] Size:25G facilitating advancements in pharmaceuticals andN Chloromethylphthalimide is widely utilized in research focused on: HPLC Labeling: It serves as a crucial reagent for labeling compounds in High Performance Liquid Chromatography (HPLC), enhancing the detection and quantification of various analytes. Peptide Synthesis: This compound is used in the synthesis of peptides, allowing for the introduction of chloromethyl groups that can be further modified, which is essential in drug development.